Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma

Published:2010 Issue:3 Volume:56 Page:234-238
ISSN:1421-9794
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Hollebecque Antoine,Bouché Olivier,Romano Olivier,Scaglia Elodie,Cattan Stéphane,Zerbib Philippe,Heurgue Alexandra,Lagarde Stéphanie,Mariette Christophe,Triboulet Jean-Pierre,Pruvot François-René,Hebbar Mohamed

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholangiozelluläres Karzinom beim alten und geriatrischen Patienten;Geriatrische Onkologie;2018

2. Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study;Oncology;2017-09-21

3. Cholangiozelluläres Karzinom beim alten und geriatrischen Patienten;Geriatrische Onkologie;2017

4. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers;Acta Oncologica;2016-06-22

5. Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma;Acta Oncologica;2015-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP